Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Effects of Methylphenidate on Cognitive Fatigue in Multiple Sclerosis: a Double-blind, Placebo-controlled, Randomized Clinical Trial

NCT02286557 is registered in ClinicalTrials.gov with Kessler Foundation as lead sponsor.

NCT NCT02286557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02286557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Effects of Methylphenidate on Cognitive Fatigue in Multiple Sclerosis: a Double-blind, Placebo-controlled, Randomized Clinical Trial
Lead sponsor
Kessler Foundation
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
March 4, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue in multiple sclerosis